Gunday, Aldrin, JR.. M.

HRN: 27-50-85  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2025
CEFUROXIME 750MG (VIAL)
07/23/2025
07/29/2025
IV
370mg
Q8h
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: